Related Experiment Video

Updated: Aug 17, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Therapeutic vaccines for prostate cancer: a review of clinical data

Philip M Arlen1, James L Gulley

  • 1Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892-1750, USA. pa52s@nih.gov

Current Opinion in Investigational Drugs (London, England : 2000)
|July 2, 2005
PubMed

Insights

This review explores advances in prostate cancer vaccines, including whole tumor cells, dendritic cells, and viral vectors. It summarizes clinical studies, highlighting progress in harnessing the immune system to fight prostate cancer.

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • Prostate cancer is a leading cause of cancer death in US men.
  • Advances in immunology have spurred new prostate cancer vaccine development.
  • Understanding immune principles is key to novel therapeutic strategies.

Purpose of the Study:

  • To review the rationale behind prostate cancer vaccine development.
  • To discuss vaccines utilizing whole tumor cells, dendritic cells, and viral vectors.
  • To summarize clinical studies of these novel vaccine strategies.

Main Methods:

  • Literature review of immunological principles and vaccine strategies.
  • Analysis of rationale for whole tumor cell, dendritic cell, and viral vector vaccines.
  • Summary of selected clinical trial data for prostate cancer vaccines.

Main Results:

  • Vaccine strategies discussed show promise in preclinical and clinical settings.
  • Pox viral vectors offer a platform for delivering tumor antigens.
  • Dendritic cell vaccines aim to enhance anti-tumor immune responses.

Conclusions:

  • Prostate cancer vaccine development is rapidly advancing.
  • Multiple strategies, including cellular and vector-based vaccines, are being investigated.
  • Further clinical studies are needed to establish efficacy and optimize treatment.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...